Sustained Patient Meaningful Outcomes of Pain and Fatigue Relief and Improved Physical Functioning with Filgotinib in Rheumatoid Arthritis: A Post Hoc Analysis

被引：0
|
作者：
Alten, Rieke [1 ]
Fautrel, Bruno [2 ,3 ]
Conaghan, Philip G. [4 ,5 ]
de Vries, Dick [6 ]
Faes, Margaux [7 ]
Piovesan, Mercedes [8 ]
Van Beneden, Katrien [9 ]
Watson, Chris [10 ]
Weel-Koenders, Angelique E. A. M. [11 ,12 ]
Feist, Eugen [13 ]
de Vlam, Kurt [14 ,15 ]
机构：
[1] Univ Med Berlin, Dept Internal Med & Rheumatol, Schlosspark Klin, Berlin, Germany
[2] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMRS 1136, Paris, Ile De France, France
[3] Sorbonne Univ, Hop Pitie Salpetriere, Assistance Publ Hop Paris, Dept Rhumatol, Paris, Ile De France, France
[4] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England
[5] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, England
[6] Galapagos BV, Clin Dev, Leiden, Netherlands
[7] Galapagos NV, Biostat, Mechelen, Belgium
[8] Galapagos Biopharma Spain SLU, Med Affairs, Madrid, Spain
[9] Galapagos NV, Med Affairs, Mechelen, Belgium
[10] Galapagos Biotech Ltd, Med Affairs, Cambridge, England
[11] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands
[12] Maasstad Hosp, Dept Rheumatol & Clin Immunol, Rotterdam, Netherlands
[13] Otto von Guericke Univ, Helios Clin Vogelsang Gommern, Department Rheumatol, Gommern, Germany
[14] UZ Leuven, Dept Rheumatol, Leuven, Belgium
[15] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0518
引用
收藏
页码：1052 / 1055
页数：4
相关论文
共 50 条
  • [31] Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis
    Fleischmann, Roy
    Hayes, Kyle
    Ahn, Sung-Woo
    Wan, George J.
    Panaccio, Mary P.
    Karlsson, Daniel
    Furst, Daniel E.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 435 - 446
  • [32] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, P.
    Downie, B.
    Liu, J.
    Hawtin, R.
    Curtis, J. R.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 502 - 502
  • [33] Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials
    Tanaka, Yoshiya
    Atsumi, Tatsuya
    Aletaha, Daniel
    Bartok, Beatrix
    Pechonkina, Alena
    Han, Ling
    Emoto, Kahaku
    Kano, Shungo
    Rajendran, Vijay
    Takeuchi, Tsutomu
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 161 - 185
  • [34] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, Paul
    Downie, Bryan
    Liu, Jinfeng
    Hawtin, Rachael E.
    Curtis, Jeffrey R.
    Burmester, Gerd R.
    RHEUMATOLOGY, 2022, 61
  • [35] Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies
    Maassen, Johanna Maria
    Sobrin, Raquel Dos Santos
    Bergstra, Sytske Anne
    Goekoop, Robbert
    Huizinga, Tom W. J.
    Allaart, Cornelia F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (09) : 1124 - 1129
  • [36] Association between Clinical Response and Normalization of Patient-Reported Outcome Measures in Rheumatoid Arthritis: Post-Hoc Analysis from Two Phase 2b Filgotinib Studies
    Genovese, Mark C.
    Van der Aa, Annegret
    Jamoul, Corinne
    Tasset, Chantal
    Harrison, Pille
    Westhovens, Rene
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [37] RADIOGRAPHIC CHANGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ESTIMATED BASELINE YEARLY PROGRESSION ≥5 OR <5: POST HOC ANALYSIS OF TWO PHASE 3 TRIALS OF FILGOTINIB
    Tanaka, Y.
    Atsumi, T.
    Aletaha, D.
    Landewe, R. B. M.
    Bartok, B.
    Pechonkina, A.
    Yin, Z.
    Han, L.
    Emoto, K.
    Kano, S.
    Rajendran, V.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 604 - 605
  • [38] LONG-TERM CLINICAL PROFILE OF FILGOTINIB (FIL) IN PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA) BY CARDIOVASCULAR (CV) RISK FACTORS: A POST HOC SUBGROUP ANALYSIS
    Buch, M. H.
    Gomez-Puerta, J. A.
    Burmester, G. R.
    Combe, B.
    Rajendran, V.
    Stiers, P. J.
    Van Hoek, P.
    Van Beneden, K.
    Gottenberg, J. E.
    Tanaka, Y.
    Aletaha, D.
    Westhovens, R.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 397 - 398
  • [39] Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib
    Pope, Janet E.
    Lee, Yvonne C.
    Curtis, Jeffrey R.
    Mo, Daojun
    Xie, Li
    Dickson, Christina L.
    Schlichting, Douglas E.
    Cardoso, Anabela
    Simon, Lee S.
    Taylor, Peter C.
    ACR OPEN RHEUMATOLOGY, 2022, 4 (03) : 254 - 258
  • [40] Radiographic Change in Patients with Rheumatoid Arthritis and Estimated Baseline Yearly Progression ≥5 or <5: Post Hoc Analysis of Two Phase 3 Trials of Filgotinib
    Tanaka, Yoshiya
    Atsumi, Tatsuya
    Aletaha, Daniel
    Landewe, Robert
    Bartok, Beatrix
    Pechonkina, Alena
    Han, Ling
    Emoto, Kahaku
    Kano, Shungo
    Rajendran, Vijay
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 581 - 584
12345